PCS-2023 > 3 > 3E > 3E0 > 3E0S |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0S | Introduction, Epidural Space | |
3E0S3 | Percutaneous | |
3E0S30 | Antineoplastic | |
3E0S302 | Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach | |
3E0S303 | Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach | |
3E0S304 | Introduction of Liquid Brachytherapy Radioisotope into Epidural Space, Percutaneous Approach | |
3E0S305 | Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach | |
3E0S30M | Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach | |
3E0S32 | Anti-infective | |
3E0S328 | Introduction of Oxazolidinones into Epidural Space, Percutaneous Approach | |
3E0S329 | Introduction of Other Anti-infective into Epidural Space, Percutaneous Approach | |
3E0S33 | Anti-inflammatory | |
3E0S33Z | Introduction of Anti-inflammatory into Epidural Space, Percutaneous Approach | |
3E0S36 | Nutritional Substance | |
3E0S36Z | Introduction of Nutritional Substance into Epidural Space, Percutaneous Approach | |
3E0S37 | Electrolytic and Water Balance Substance | |
3E0S37Z | Introduction of Electrolytic and Water Balance Substance into Epidural Space, Percutaneous Approach | |
3E0S3B | Anesthetic Agent | |
3E0S3BZ | Introduction of Anesthetic Agent into Epidural Space, Percutaneous Approach | |
3E0S3H | Radioactive Substance | |
3E0S3HZ | Introduction of Radioactive Substance into Epidural Space, Percutaneous Approach | |
3E0S3K | Other Diagnostic Substance | |
3E0S3KZ | Introduction of Other Diagnostic Substance into Epidural Space, Percutaneous Approach | |
3E0S3N | Analgesics, Hypnotics, Sedatives | |
3E0S3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Epidural Space, Percutaneous Approach | |
3E0S3T | Destructive Agent | |
3E0S3TZ | Introduction of Destructive Agent into Epidural Space, Percutaneous Approach | |
3E0S3G | Other Therapeutic Substance | |
3E0S3GC | Introduction of Other Therapeutic Substance into Epidural Space, Percutaneous Approach | |
3E0S3S | Gas | |
3E0S3SF | Introduction of Other Gas into Epidural Space, Percutaneous Approach | |
3E0S7 | Via Natural or Artificial Opening | |
3E0S7S | Gas | |
3E0S7SF | Introduction of Other Gas into Epidural Space, Via Natural or Artificial Opening |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |